Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Broner

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|June 10, 2022
Patients' Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World StudyCyril Dumain, Jonathan Broner, Erik Arnaud, et al.
Kidney International Reports|January 16, 2023
C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous NephropathyMaxime Teisseyre, Anaïs Beyze, Hélène Perrochia, et al.
Frontiers in Medicine|December 3, 2021
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)Alfred Mahr, Eric Hachulla, Hubert de Boysson, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
British Journal of Haematology|June 21, 2021
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life studyThibault Comont, Mathieu Meunier, Amina Cherait, et al.
Autoimmunity Reviews|July 15, 2017
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patientsArsene Mekinian, Guillaume Dervin, Nathanael Lapidus, et al.
Haematologica|February 25, 2021
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaVincent Jachiet, Guillaume Moulis, Jérome Hadjadj, et al.
Rheumatology (Oxford, England)|October 11, 2023
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture methodEmma Rubenstein, Pierrick Henneton, Sophie Rivière, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|June 10, 2022
Patients' Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World StudyCyril Dumain, Jonathan Broner, Erik Arnaud, et al.
Kidney International Reports|January 16, 2023
C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous NephropathyMaxime Teisseyre, Anaïs Beyze, Hélène Perrochia, et al.
Frontiers in Medicine|December 3, 2021
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)Alfred Mahr, Eric Hachulla, Hubert de Boysson, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
British Journal of Haematology|June 21, 2021
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life studyThibault Comont, Mathieu Meunier, Amina Cherait, et al.
Autoimmunity Reviews|July 15, 2017
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patientsArsene Mekinian, Guillaume Dervin, Nathanael Lapidus, et al.
Haematologica|February 25, 2021
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaVincent Jachiet, Guillaume Moulis, Jérome Hadjadj, et al.
Rheumatology (Oxford, England)|October 11, 2023
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture methodEmma Rubenstein, Pierrick Henneton, Sophie Rivière, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 3